Skip to content

DR. ALINE MADOE

Active
Private limited companyfounded 20223 yrs activeDoelstraat 31, 3540 Herk-de-Stad, BelgiumKBO/BCE: BE 0792.844.247

DR. ALINE MADOE has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €217k and a net result of €99k. Equity is growing by ~81.8% per year across the filed fiscal years. Its solvency ranks better than 68% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
97 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
Liquidity ample (current ratio 4.79 against 4.94 in 2024; short-term debt: 20.7% and cash: 50.9% of total assets), and 21.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
78.9%
Return on assets
36%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-04-2026, 95 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
95 d early
2024
16 d early
2023
13 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€217k▲ 83.8%
2024 · €118k
2023: €24k 2024: €118k
2023 → 2025
Total assets
€275k▲ 87.0%
2024 · €147k
2023: €32k 2024: €147k
2023 → 2025
Net result
€99k▲ 4.9%
2024 · €94k
2023: €20k 2024: €94k
2023 → 2025
Working capital
€216k▲ 93.9%
2024 · €111k
2023: €13k 2024: €111k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€24k-€118k▲ 397%€217k▲ 83.8%
Operating result€27k-€120k▲ 353%€123k▲ 1.8%
Net result€20k-€94k▲ 365%€99k▲ 4.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2023: €27k€27kNet result 2023: €20k€20kOperating result 2024: €120k€120kNet result 2024: €94k€94kOperating result 2025: €123k€123kNet result 2025: €99k€99k202320242025
The operating result has risen two years in a row; 2025 is 2% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €275k
Fixed assets €3k▼ 64.4%
Current assets €272k▲ 95.5%
Equity and liabilities €275k
Equity €217k▲ 83.8%
Debt €58k▲ 99.9%
The debt ratio rises from 19.8% to 21.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€128k
2024 · €125k
Cash flow
€104k
2024 · €99k
Solvency
78.9%
2024 · 80.2%
Current ratio
4.79
2024 · 4.94
Quick ratio
4.79
2024 · 4.94
Debt / equity
0.27
2024 · 0.25
ROE
45.6%
2024 · 79.9%
ROA
36.0%
2024 · 64.1%
Interest coverage
1116.21
2024 · 1205.33
Debt
€58k
2024 · €29k
Debt ≤ 1 year
€57k
2024 · €28k
Income taxes
€28k
2024 · €27k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€147k€275k
Fixed assets21/28€8k€3k
Tangible fixed assets22/27€8k€3k
Plant, machinery and equipment23€791-
Furniture and vehicles24€7k€3k
Current assets29/58€139k€272k
Amounts receivable within one year40/41€44k€94k
Other amounts receivable41€44k€94k
Current investments50/53-€30k
Cash at bank and in hand54/58€75k€140k
Deferred charges and accrued income490/1€20k€8k
Equity and liabilities
Total equity and liabilities10/49€147k€275k
Equity10/15€118k€217k
Contributions10/11€4k€4k=
Reserves13€115k€214k
Distributable reserves133€115k€214k
Amounts payable17/49€29k€58k
Amounts payable within one year42/48€28k€57k
Trade debts44€1k€2k
Suppliers440/4€1k€2k
Taxes, remuneration and social security45€27k€55k
Taxes450/3€27k€55k
Accrued charges and deferred income492/3€900€1k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k
Other operating charges640/8€1k€1k
Gross operating margin9900€126k€129k
Operating profit (loss)9901€120k€123k
Financial income75/76B€684€5k
Recurring financial income75€684€5k
Financial charges65/66B€104€114
Recurring financial charges65€104€114
Profit (loss) for the period before taxes9903€121k€127k
Income taxes67/77€27k€28k
Profit (loss) for the period9904€94k€99k
Profit (loss) for the period to be appropriated9905€94k€99k
Appropriation of the result
Profit (loss) to be appropriated9906€94k€99k
Transfer to equity691/2€94k€99k
To other reserves6921€94k€99k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-04
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2023net €99k ▲4.9%
Operating result €123k, net result €99k, both a record.
31-12
Financial Equity above €200kEq €217k ▲83.8%
3 profitable years in a row build equity to €217k.
15-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Equity above €100kEq €118k ▲397%
2 profitable years in a row build equity to €118k.
18-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herk-de-Stad · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Doelstraat 313540 Herk-de-Stad
Ground area
3,341 m²
Building footprint
211 m²
Volume, LiDAR
1,110 m³
Parcel 71024A0403/00M000, Flanders · tallest building 7.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Doelstraat 31, 3540 Herk-de-Stad
Specialist medical practice
since 20222.337.657.141
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71024A0403/00M000 Flanders 3,341 m² 1 · 211 m² 7.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,661 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded25-10-2022
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.